Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Clinical trial NCT04527991 · COMPLETED
Trial details
- NCT number
- NCT04527991
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2025-07-04
- Enrollment
- 711
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.